血栓通联合长春西汀治疗突发性聋的临床观察
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
血栓通联合长春西汀治疗突发性聋的临床观察
张潜英;岳显;韦军;黄坚;唐正其
【期刊名称】《中国中西医结合耳鼻咽喉科杂志》
【年(卷),期】2013(000)006
【摘要】Objective To investigate the effect of Xueshuantong with Vinpocetine on Sudden hearing loss.Methods 92 patients (114 ears) with Sudden hearing loss were randomly divided into the treatment group
(n=59 ears) and the control group (n=55 ears).Except intravenous administration of Xueshuantong with Vinpocetine,other treatments in the treatment group were the same as in the control group, including vasodilator,hyperbaric oxygen, energy preparation such as ATP and dexamethasone. Results The hearing threshold was recovery in 27 ears, significant improved in 18 ears, improved in 7 ears, and kept no changed
in 7 ears in treatment group. While in the control group,the hearing threshold was recovered in 12 ears, significant improved in 13 ears, improved in 15 ears, and no changed in 15 ears.There was significant difference between the two groups (P﹤0.05).Conclusion The application of Xueshuantong combined with Vinpocetine could significantly improve the effect of treatment on Sudden hearing loss.%目的:对血栓通联合长春西汀治疗突发性聋的疗效进行临床观察。
方法92例(114耳)突发性聋患者按就诊顺序分
成实验组50例(59耳)和对照组42例(55耳)。
实验组血栓通联合长春西汀治疗,
对照组用复方丹参治疗;两组均常规行激素、能量合剂、高压氧、B族维生素治疗。
两组在治疗前和治疗后4d开始每3d用纯音电测听测试患者听力。
结果经治疗后,实验组50例(59耳)中痊愈23例(27耳),显效16例(18耳),有效6例(7耳),无效5例(7耳),治愈率为45.8%,对照组42例(55耳)中痊愈9例(12耳),显效
8例(13耳),有效15例(15耳),无效10例(15耳),治愈率为21.8%,两组统
计学处理差异有显著性(P﹤0.05)。
结论血栓通联合长春西汀治疗突发性聋能显
著提高疗效。
【总页数】3页(P413-414,417)
【作者】张潜英;岳显;韦军;黄坚;唐正其
【作者单位】四川省自贡市第三人民医院耳鼻咽喉科 643020;四川省自贡市第三
人民医院耳鼻咽喉科 643020;四川省自贡市第三人民医院耳鼻咽喉科 643020;四
川省自贡市第三人民医院耳鼻咽喉科 643020;四川省自贡市第三人民医院耳鼻咽
喉科 643020
【正文语种】中文
【相关文献】
1.血栓通联合长春西汀治疗突发性聋50例临床观察 [J], 张潜英;岳显;韦军;黄坚;唐正其
2.巴曲酶联合甲强龙和长春西汀治疗全频型突发性聋的临床疗效观察 [J], 邵美君;焦粤龙
3.血栓通治疗突发性聋的临床观察 [J], 杨桂华;王勇;肖阳
4.长春西汀联合益气聪明汤治疗TCD异常突发性聋的疗效观察 [J], 陈玉卿;孙宣东;邹嘉平
5.中医辨证联合长春西汀注射液治疗伴发眩晕的突发性聋的效果 [J], 江坚;郑妮亚;黄丽燕
因版权原因,仅展示原文概要,查看原文内容请购买。